SEBI Registration NO.---- INA000001530 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS or messenger.

Top Ten Stocks to be Focused for 1 June 2016

Top Ten Stocks to be Focused for 1 June 2016

The Indian market is expected to open higher on Wednesday tracking positive trend seen in other Asian markets.

Here is a list of top Ten stocks that are likely to be in focus today:

Maruti Suzuki: M aruti Suzuki said it will resume production of vehicles at its Gurgaon facilities from the second half on Wednesday. The company had to suspend operations at its facilities on Monday, following a fire at the Manesar factory of its supplier Subros BSE 2.28 %.

PVR & DLF: PVR, India’s leading multiplex operator, has closed a deal to acquire real estate company DLF’s cinema exhibition business, branded DT Cinemas , with fewer screens than originally planned.

Reliance Industries: RIL is running at lower capacity at some plants and is undertaking shut down of two of its petrochemical units at Dahej in Gujarat in response to insufficient water to run the units, the company informed bourses on Tuesday.

Tata Motors: Tata Motors-owned luxury car manufacturer Jaguar Land Rover (JLR) broke the half a million mark for the first time in its history as per its latest vehicle sales results released this week.

State run oil companies: Petrol price was hiked by Rs 2.58 a litre and diesel by Rs 2.26 per litre, the second increase in rates this month. Petrol will cost Rs 65.60 per litre in DELHI after the increase while diesel will cost Rs 53.93/litre.

ONGC: ONGC Videsh Ltd, the overseas arm of state-owned Oil and Natural Gas BSE 0.64 % Corp ( ONGC BSE 0.64 %) has signed a pact with the trading arm of Azerbaijan’s state energy company SOCAR to foray into oil trading.

Axis Bank: Reserve Bank has allowed Axis Bank to raise foreign shareholding to up to 62 per cent, from the earlier limit of 49 per cent.

Sun Pharma: India’s largest drug maker Sun Pharma BSE 0.69 % has said it expects 8-10% growth in sales in 2016-17, aided by “traction” across its businesses, and cautioned that a planned investment in the US is likely to impact short-term profits.

Aurobindo Pharma: Indian drug firm with the highest number of USFDA product approvals, proposes to focus on increased Abbreviated New Drug Application (ANDA) filings and new differentiated product launches to maintain its growth.

Andhra Bank: Public sector Andhra Bank BSE 0.40 % said that it plans to raise Rs 2,700 crore for 2016-17, as per the financial requirements of the fiscal. The decision was taken at the bank’s Board of Directors meeting held yesterday.

error: Content is protected !!